Beth C. Vetelino
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Drug Transport and Resistance Mechanisms, Fluorine in Organic Chemistry, Sulfur-Based Synthesis Techniques, Synthesis and Catalytic Reactions
Most-Cited Works
- → Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications(2014)131 cited
- → SuFEx Activation with Ca(NTf 2 ) 2 : A Unified Strategy to Access Sulfamides, Sulfamates, and Sulfonamides from S(VI) Fluorides(2020)130 cited
- → Optimization of Tubulysin Antibody–Drug Conjugates: A Case Study in Addressing ADC Metabolism(2016)70 cited
- → Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads(2016)37 cited
- → Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability(2015)32 cited
- → Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators(2012)31 cited
- → Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators(2014)29 cited
- → Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer(2024)17 cited
- → Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease(2024)6 cited
- → SuFEx Activation with Ca(NTf2)2: A Unified Strategy to Access Sulfamides, Sulfamates and Sulfonamides from S(VI) Fluorides(2020)6 cited